ArticleEarly intervention in psychiatry2025
Transdiagnostic Symptom Dimensions in Individuals at Ultra-High Risk for Psychosis: Towards Dimensional Representations of Pluripotent Risk.
Article in Early intervention in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transdiagnostic Symptom Dimensions in Individuals at Ultra-High Risk for Psychosis: Towards Dimensional Representations of Pluripotent Risk.Early intervention in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introResearch has shifted focus from categorical to dimensional conceptualisations of mental health conditions. This is supported by high overlap between disorders, particularly psychosis spectrum and affective disorders, which cuts across traditional diagnostic boundaries. While there is evidence for a general factor of psychopathology in individuals with schizophrenia, schizoaffective disorder, and psychotic bipolar I disorder, transdiagnostic dimensions of psychopathology have not been investigated in young individuals at ultra-high risk for psychosis, that is, youth with pluripotent symptom patterns preceding first-episode psychosis. The current study sought to investigate (1) whether there is a general dimension underlying psychopathological symptoms in individuals and (2) whether the formation of specific symptom dimensions (i.e., positive symptoms, negative symptoms, affect, and activation) is justified alongside a general dimension.
methodsItem factor analyses were conducted on symptom ratings of the Brief Psychiatric Rating Scale at baseline in the Staged Treatment in Early Psychosis (STEP) trial.
resultsIn total, 342 UHR participants were included. A bifactor model with one general symptom dimension and four specific factors (positive symptoms, negative symptoms, affect, and activation) yielded the best relative model fit and interpretability when compared to uni- and multidimensional models, albeit absolute model fit statistics provided no strong evidence to support this finding. However, model stability and interpretability tentatively suggest it can help tell apart pluripotent and domain-specific symptom patterns.
conclusionFindings cautiously suggest that the BPRS may index both a general dimension and several more specific dimensions, reflecting pluripotency underlying psychological features in the sample. A 'common ground' across the risk syndrome in this heterogeneous sample, with various comorbidities, would lend further evidence to support the notion of a transdiagnostic phenotype in youth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.